GeneDx Hldgs Analyst Ratings
GeneDx Hldgs Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/01/2023 | 231.49% | Goldman Sachs | $7 → $6 | Maintains | Neutral |
08/09/2023 | 286.74% | Goldman Sachs | $8 → $7 | Maintains | Neutral |
07/24/2023 | 341.99% | Goldman Sachs | $9 → $8 | Maintains | Neutral |
07/21/2023 | 341.99% | Goldman Sachs | $9 → $8 | Maintains | Neutral |
05/15/2023 | 397.24% | Goldman Sachs | $33 → $9 | Maintains | Neutral |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
11/01/2023 | 231.49% | 高盛 | 7 美元 → 6 美元 | 維護 | 中立 |
08/09/2023 | 286.74% | 高盛 | 8 美元 → 7 美元 | 維護 | 中立 |
2023 年 7 月 24 日 | 341.99% | 高盛 | 9 美元 → 8 美元 | 維護 | 中立 |
07/21/2023 | 341.99% | 高盛 | 9 美元 → 8 美元 | 維護 | 中立 |
05/15/2023 | 397.24% | 高盛 | 33 美元 → 9 美元 | 維護 | 中立 |
What is the target price for GeneDx Hldgs (WGS)?
GenedX Hldgs (WGS) 的目標價格是多少?
The latest price target for GeneDx Hldgs (NASDAQ: WGS) was reported by Goldman Sachs on November 1, 2023. The analyst firm set a price target for $6.00 expecting WGS to rise to within 12 months (a possible 231.49% upside). 5 analyst firms have reported ratings in the last year.
高盛於2023年11月1日公佈了GenedX Hldgs(納斯達克股票代碼:WGS)的最新目標股價。該分析公司將目標股價定爲6.00美元,預計WGS將在12個月內升至12個月內(可能上漲231.49%)。去年有5家分析公司公佈了評級。
What is the most recent analyst rating for GeneDx Hldgs (WGS)?
分析師對GenedX Hldgs(WGS)的最新評級是多少?
The latest analyst rating for GeneDx Hldgs (NASDAQ: WGS) was provided by Goldman Sachs, and GeneDx Hldgs maintained their neutral rating.
GenedX Hldgs(納斯達克股票代碼:WGS)的最新分析師評級由高盛提供,GenedX Hldgs維持中性評級。
When is the next analyst rating going to be posted or updated for GeneDx Hldgs (WGS)?
GenedX Hldgs(WGS)的下一個分析師評級何時公佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GeneDx Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GeneDx Hldgs was filed on November 1, 2023 so you should expect the next rating to be made available sometime around November 1, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與GenedX Hldgs的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級,因此每家公司每年應該獲得4次評級。GenedX Hldgs的最新評級是在2023年11月1日公佈的,因此您應該預計下一個評級將在2024年11月1日左右公佈。
Is the Analyst Rating GeneDx Hldgs (WGS) correct?
分析師對 GeneDX Hldgs (WGS) 的評級正確嗎?
While ratings are subjective and will change, the latest GeneDx Hldgs (WGS) rating was a maintained with a price target of $7.00 to $6.00. The current price GeneDx Hldgs (WGS) is trading at is $1.81, which is out of the analyst's predicted range.
儘管評級是主觀的,並且會發生變化,但最新的GenedX Hldgs(WGS)評級維持不變,目標股價爲7.00美元至6.00美元。GenedX Hldgs(WGS)目前的交易價格爲1.81美元,超出了分析師的預期區間。
譯文內容由第三人軟體翻譯。